相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Synaptic density and cognitive performance in Alzheimer's disease: A PET imaging study with [11C]UCB-J
Adam P. Mecca et al.
ALZHEIMERS & DEMENTIA (2022)
Regional amyloid correlates of cognitive performance in ageing and mild cognitive impairment
Daniel A. Stevens et al.
BRAIN COMMUNICATIONS (2022)
Vortioxetine improves cognition in mild cognitive impairment
Sheng Neng Tan et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2021)
Positron emission tomography imaging of serotonin degeneration and beta-amyloid deposition in late-life depression evaluated with multi-modal partial least squares
Gwenn S. Smith et al.
TRANSLATIONAL PSYCHIATRY (2021)
Neuroinflammation and amyloid-beta 40 are associated with reduced serotonin transporter (SERT) activity in a transgenic model of familial Alzheimer's disease
Athanasios Metaxas et al.
ALZHEIMERS RESEARCH & THERAPY (2019)
Molecular imaging of serotonin degeneration in mild cognitive impairment
Gwenn S. Smith et al.
NEUROBIOLOGY OF DISEASE (2017)
Time to Amyloid Positivity and Preclinical Changes in Brain Metabolism, Atrophy, and Cognition: Evidence for Emerging Amyloid Pathology in Alzheimer's Disease
Philip S. Insel et al.
FRONTIERS IN NEUROSCIENCE (2017)
Meta-analysis of synaptic pathology in Alzheimer's disease reveals selective molecular vesicular machinery vulnerability
Martijn C. de Wilde et al.
ALZHEIMERS & DEMENTIA (2016)
Mapping the distribution of serotonin transporter in the human brainstem with high-resolution PET: Validation using postmortem autoradiography data
P. Fazio et al.
NEUROIMAGE (2016)
Serotonin: A New Hope in Alzheimer's Disease?
Sylvie Claeysen et al.
ACS CHEMICAL NEUROSCIENCE (2015)
5-HT1B and other related serotonergic proteins are altered in APPswe mutation
Walid Tajeddinn et al.
NEUROSCIENCE LETTERS (2015)
Comparison of Four Verbal Memory Tests for the Diagnosis and Predictive Value of Mild Cognitive Impairment
Dina Silva et al.
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS EXTRA (2012)
Cerebral Serotonin 4 Receptors and Amyloid-beta in Early Alzheimer's Disease
Karine Madsen et al.
JOURNAL OF ALZHEIMERS DISEASE (2011)
The Reduction of Baseline Serotonin 2A Receptors in Mild Cognitive Impairment is Stable at Two-year Follow-up
Lisbeth Marner et al.
JOURNAL OF ALZHEIMERS DISEASE (2011)
Synaptic Loss in the Inferior Temporal Gyrus in Mild Cognitive Impairment and Alzheimer's Disease
Stephen W. Scheff et al.
JOURNAL OF ALZHEIMERS DISEASE (2011)
Predicting conversion from mild cognitive impairment to Alzheimer's disease using neuropsychological tests and multivariate methods
Robert M. Chapman et al.
JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY (2011)
Decreased cerebral cortical serotonin transporter binding in ecstasy users: a positron emission tomography/[11C]DASB and structural brain imaging study
Stephen J. Kish et al.
BRAIN (2010)
Pittsburgh Compound B Imaging and Prediction of Progression From Cognitive Normality to Symptomatic Alzheimer Disease
John C. Morris et al.
ARCHIVES OF NEUROLOGY (2009)
Mild Cognitive Impairment Ten Years Later
Ronald C. Petersen et al.
ARCHIVES OF NEUROLOGY (2009)
Amyloid imaging in aging and dementia: Testing the amyloid hypothesis in vivo
G. D. Rabinovici et al.
BEHAVIOURAL NEUROLOGY (2009)
Serial PIB and MRI in normal, mild cognitive impairment and Alzheimers disease: implications for sequence of pathological events in Alzheimers disease
Clifford R. Jack et al.
BRAIN (2009)
The dorsal raphe nucleus shows phospho-tau neurofibrillary changes before the transentorhinal region in Alzheimer's disease. A precocious onset?
L. T. Grinberg et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2009)
Amyloid Pathology Is Associated with Progressive Monoaminergic Neurodegeneration in a Transgenic Mouse Model of Alzheimer's Disease
Ying Liu et al.
JOURNAL OF NEUROSCIENCE (2008)
A beta deposits in older non-demented individuals with cognitive decline are indicative of preclinical Alzheimer's disease
V. L. Villemagne et al.
NEUROPSYCHOLOGIA (2008)
Does fluoxetine have any effect on the cognition of patients with mild cognitive impairment? A double-blind, placebo-controlled, clinical trial
Arash Mowla et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2007)
Two-year follow-up of amyloid deposition in patients with Alzheimer's disease
Henry Engler et al.
BRAIN (2006)
An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest
Rahul S. Desikan et al.
NEUROIMAGE (2006)
Serotonin and human cognitive performance
J. A. J. Schmitt et al.
CURRENT PHARMACEUTICAL DESIGN (2006)
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B
WE Klunk et al.
ANNALS OF NEUROLOGY (2004)
Differential involvement of 5-HT1B/1D and 5-HT6 receptors in cognitive and non-cognitive symptoms in Alzheimer's disease
M Garcia-Alloza et al.
NEUROPSYCHOPHARMACOLOGY (2004)
A rapid one-step radiosynthesis of the β-amyloid imaging radiotracer N-methyl-[11C]2-(4′-methylaminophenyl)-6-hydroxybenzothiazole ([11C]-6-OH-BTA-1)
AA Wilson et al.
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS (2004)
Autoradiographic distribution of serotonin transporters and receptor subtypes in human brain
K Varnäs et al.
HUMAN BRAIN MAPPING (2004)
Linearized reference tissue parametric Imaging methods:: Application to [11C]DASB positron emission tomography studies of the serotonin transporter in human brain
M Ichise et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2003)
Neuron loss in key cholinergic and aminergic nuclei in Alzheimer disease: a meta-analysis
SA Lyness et al.
NEUROBIOLOGY OF AGING (2003)
In vitro and in vivo characterisation of [11C]-DASB:: a probe for in vivo measurements of the serotonin transporter by positron emission tomography
AA Wilson et al.
NUCLEAR MEDICINE AND BIOLOGY (2002)
Whole brain segmentation: Automated labeling of neuroanatomical structures in the human brain
B Fischl et al.
NEURON (2002)
分享论文
